The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | S | Sensory organs | |
| 2 | S01 | Ophthalmologicals | |
| 3 | S01G | Decongestants and antiallergics | |
| 4 | S01GX | Other antiallergics | |
| 5 | S01GX10 | Epinastine |
| Active Ingredient | Description | |
|---|---|---|
| Epinastine |
Epinastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H1-receptor and has affinity for the histamine H2 |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ELESTAT Ophthalmic solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| RELESTAT Eye drops, solution | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
